Good treatment starts with the right tests. Here is what each one tells us, and why some need to be repeated.
Histopathology report (sample)
Sample report for learning. Not a real patient.
The type of cancer. 'Carcinoma' starts in the lining cells of an organ; 'invasive' means it has grown beyond the lining. 'In situ' would mean it has not.
How different the cancer cells look from normal cells. Grade 1 looks closest to normal and grows slowly; grade 3 grows faster. Grade is different from stage.
The size of the cancer measured in the removed tissue. Used for the stage.
Whether there is a rim of normal tissue around the cancer. Clear (negative) margins mean the cancer was removed completely. Involved (positive) margins may need more surgery or radiotherapy.
How many lymph nodes were removed (15) and how many had cancer (2). Spread to nodes raises the stage and often means more treatment.
Cancer cells seen inside small blood or lymph vessels. It slightly increases the risk of spread and helps decide treatment after surgery.
T is the size and extent of the tumour, N the lymph nodes. The small 'p' means it is based on the removed tissue. Your doctor combines this with scans to give the full stage.
The proportion of cancer cells that are dividing. A higher number means faster growth. Mainly used in breast cancer and neuroendocrine tumours.
Tap each line to see what it means.
IHC (immunohistochemistry) uses special stains on the biopsy to look for proteins that guide treatment.
| Test | Used in | What the result means |
|---|---|---|
| ER and PR | Breast, womb | Positive: hormonal therapy will work. Reported as a percentage or score. |
| HER2 | Breast, stomach | 0, 1+, 2+ or 3+. 3+ is positive: HER2 medicines work. 2+ is borderline: a FISH test decides. 1+ or 2+ without amplification is 'HER2-low', which matters for some newer medicines. |
| PD-L1 | Lung, head and neck, stomach, others | Reported as TPS or CPS. Higher numbers mean immunotherapy is more likely to work. |
| MMR / MSI | Bowel, womb, many others | MMR deficient (MSI-high): immunotherapy works very well; may suggest Lynch syndrome. |
| ALK, ROS1 | Lung | Positive: specific targeted tablets work. |
| Ki-67 | Breast, neuroendocrine | How fast the cells are dividing. |
| CT scan | MRI scan | PET-CT scan | |
|---|---|---|---|
| What it shows | Detailed pictures of the chest, abdomen, pelvis | Very detailed pictures of soft tissue: brain, liver, pelvis, spine, breast | Shows how active cells are, using a sugar tracer, together with a CT |
| How long | 5 to 10 minutes | 20 to 45 minutes, inside a tunnel, noisy | About 2 to 3 hours in all, including waiting after the injection |
| Preparation | Fasting 4 hours if contrast is used; kidney blood test | Remove all metal; tell us about pacemakers, implants or fear of closed spaces | Fast for 6 hours; water is allowed; sugar must be controlled; avoid exercise the day before |
| Radiation | Yes, small | No | Yes, small; keep away from small children and pregnant women for a few hours after |
Words often seen on PET-CT reports. Tap one to see what it means.
The area takes up more of the sugar tracer than normal tissue. Cancer often does, but so do infection, inflammation and healing tissue.
A number for how much tracer an area takes up. Higher usually means more active. It is most useful for comparing the same spot between scans, not as a single number.
The radiologist thinks the uptake is from inflammation or infection, not cancer. Your doctor will decide if any test is needed.
The finding is not clearly cancer or not cancer. Often a repeat scan, another type of scan, or a biopsy is advised.
Used in lymphoma PET scans. 1 to 3 usually means a good response; 4 or 5 means active disease may remain.
Before each chemotherapy cycle, blood tests check that it is safe to give treatment.
| Test | What it checks | Why it matters |
|---|---|---|
| Haemoglobin (Hb) | Red cells, which carry oxygen | Low: tiredness, breathlessness; may need iron or transfusion. |
| WBC and ANC (absolute neutrophil count) | White cells, which fight infection | If the ANC is low, chemotherapy may be delayed by a few days to keep you safe. |
| Platelets | Cells that help blood clot | Low: risk of bleeding; treatment may be delayed. |
| LFT and RFT | Liver and kidney function | Doses are adjusted if these are abnormal. |
Tumour markers are substances some cancers release into the blood.
| Marker | Mainly used in |
|---|---|
| CEA | Bowel cancer |
| CA-125 | Ovarian cancer |
| CA 19-9 | Pancreas and bile duct cancer |
| PSA | Prostate cancer |
| AFP | Liver cancer, testicular cancer |
| Beta-hCG | Testicular cancer, gestational trophoblastic disease |
| CA 15-3 | Breast cancer |
| LDH | Lymphoma, melanoma, testicular cancer |
| Words in the report | What they mean |
|---|---|
| Complete response | No cancer can be seen on the scan. |
| Partial response | The cancer has shrunk by about a third or more. |
| Stable disease | No significant change: not growing, not clearly shrinking. With many treatments, this is a good result. |
| Progressive disease | The cancer has grown or spread. We will discuss changing treatment. |
| No evidence of disease (NED) | No sign of cancer on tests after treatment. |
Written and medically reviewed by Dr Prathyusha Eaga, MD, DM (Medical Oncology). Last reviewed: 12 October 2026. Based on NCCN and ESMO guidelines.
Book a hospital visit, a video consultation or a second opinion.